Gastric Bypass Surgery Recruits a Gut PPAR-α-Striatal D1R Pathway to Reduce Fat Appetite in Obese Rats

Cell Metab. 2017 Feb 7;25(2):335-344. doi: 10.1016/j.cmet.2016.12.006. Epub 2017 Jan 5.

Abstract

Bariatric surgery remains the single most effective long-term treatment modality for morbid obesity, achieved mainly by lowering caloric intake through as yet ill-defined mechanisms. Here we show in rats that Roux-en-Y gastric bypass (RYGB)-like rerouting of ingested fat mobilizes lower small intestine production of the fat-satiety molecule oleoylethanolamide (OEA). This was associated with vagus nerve-driven increases in dorsal striatal dopamine release. We also demonstrate that RYGB upregulates striatal dopamine 1 receptor (D1R) expression specifically under high-fat diet feeding conditions. Mechanistically, interfering with local OEA, vagal, and dorsal striatal D1R signaling negated the beneficial effects of RYGB on fat intake and preferences. These findings delineate a molecular/systems pathway through which bariatric surgery improves feeding behavior and may aid in the development of novel weight loss strategies that similarly modify brain reward circuits compromised in obesity.

Keywords: D1R signaling; OEA; PPAR-alpha; [11C] SCH 23390; altered nutrient preference; dopamine system; fat appetite; gastric bypass surgery.

MeSH terms

  • Administration, Oral
  • Animals
  • Appetite / drug effects*
  • Body Weight / drug effects
  • Diet, High-Fat
  • Dietary Fats / pharmacology*
  • Dopamine / metabolism
  • Endocannabinoids / metabolism
  • Feeding Behavior / drug effects
  • Food Preferences / drug effects
  • Gastric Bypass*
  • Gastrointestinal Tract / drug effects
  • Gastrointestinal Tract / metabolism*
  • Intestine, Small / drug effects
  • Intestine, Small / metabolism
  • Intestine, Small / pathology
  • Male
  • Mice, Obese
  • Models, Biological
  • Neostriatum / drug effects
  • Neostriatum / metabolism*
  • Obesity / metabolism*
  • Obesity / physiopathology*
  • Oleic Acids / metabolism
  • PPAR alpha / metabolism*
  • Rats, Wistar
  • Receptors, Dopamine D1 / metabolism*
  • Signal Transduction* / drug effects
  • Vagus Nerve / drug effects
  • Vagus Nerve / metabolism
  • Weight Loss / drug effects

Substances

  • Dietary Fats
  • Endocannabinoids
  • Oleic Acids
  • PPAR alpha
  • Receptors, Dopamine D1
  • oleoylethanolamide
  • Dopamine